Activation of adenosine A2 receptors stimulates phosphoinositide metabolism in rat peripheral nerve

Journal of Neurochemistry

Volumn 66, Issue 2, 1996, Pages 613-619

  Sheldon, Rhonda L ^a   Bonasera, Lara K ^a   Eichberg, Joseph ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Adenosine analogues; Adenosine receptors; Cytidine monophosphate phosphatidic acid; Peripheral nerve; Phosphoinositides

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR BLOCKING AGENT; CARBACHOL; PHOSPHATIDYLINOSITIDE; RECEPTOR SUBTYPE; ADENOSINE; ADENOSINE RECEPTOR; CYTIDINE MONOPHOSPHORYLPHOSPHATIDATE; CYTIDINE PHOSPHATE; DRUG DERIVATIVE; GLYCEROPHOSPHOLIPID; PHENETHYLAMINE DERIVATIVE; PHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL; PURINE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; HYDROLYSIS; MALE; NERVE STIMULATION; NONHUMAN; PERIPHERAL NERVE; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SCIATIC NERVE; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; IN VITRO STUDY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALIA;

ADENOSINE; ANIMALS; CARBACHOL; CYTIDINE MONOPHOSPHATE; DRUG SYNERGISM; GLYCEROPHOSPHOLIPIDS; MALE; PHENETHYLAMINES; PHOSPHATIDIC ACIDS; PHOSPHATIDYLINOSITOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P1; SCIATIC NERVE;

EID: 0029670634     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66020613.x     Document Type: Article

References (37)

1. Alexander S. P. H., Kendall D. A., and Hill S. J. (1989) Differences in the adenosine receptors modulating inositol phosphates and cAMP accumulation in mammalian cerebral cortex. Br. J. Pharmacol. 98, 1241-1248.
2. Arend L J., Handler J. S., Rhim J. S., Gusovsky F., and Spielman W. S. (1989) Adenosine-sensitive phosphoinositide turnover in a newly established renal cell line. Am J. Physiol. 256, F1067-F1074.
3. Bell M. E., Peterson R. G., and Eichberg J. (1982) Metabolism of phospholipids in peripheral nerve from rats with chronic streptozotocin-induced diabetes: increased turnover of phosphatidylinositol-4,5-bisphosphate. J. Neurochem. 39, 192-200.
4. 2+ in cultured rabbit medullary thick limb cells. Am. J. Physiol. 260, C143-C150.
5. Day N. S., Berti-Mattera L. N., and Eichberg J. (1991) Muscarinic cholinergic receptor-mediated phosphoinositide metabolism in peripheral nerve. J. Neurochem. 56, 1905-1913.
6. 1 receptors. Biochem. J. 255, 69-77.
7. 1MF-2 cells: synergistic interactions and regulation by cyclic AMP. Biochem. Soc. Trans. 21, 1124-1129.
8. Downes C. P. and Stone M. A. (1986) Lithium-induced reduction in intracellular inositol supply in cholinergically stimulated parotid gland. Biochem. J. 234, 199-204.
9. El-Etr M., Cordier J., Glowinski J., and Premont J. (1989) A neuroglial cooperatively is required for the potentiation by 2-chloroadenosine of the muscarinic-sensitive phospholipase C in the striatum. J. Neurosci 9, 1473-1480.
10. Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P., and Williams M. (1994) Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143-156.
11. 1MF-2 smooth muscle cells. Proc. Natl. Acad. Sci. USA 89, 7330-7334.
12. Gerwins P. and Fredholm B. B. (1992b) ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. J. Biol. Chem. 267, 16081-16087.
13. Godfrey P. P. (1989) Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol. Biochem J. 258, 621-624.
14. Gray D W., Challiss R. A. J., and Nahorski S. R., (1994) Differential effects of lithium on muscarinic cholinoceptor-stimulated CMP-phosphatidate accumulation in cerebellar granule cells, CHO-M3 cells, and SH-SY5Y neuroblastoma cells. J. Neurochem. 63, 1354-1360.
15. Heacock A. M., Seguin E. B., and Agranoff B. W. (1993) Measurement of receptor-activated phosphoinositide turnover in rat brain: nonequivalence of inositol phosphate and CDP-diacylglycerol formation. J. Neurochem. 60, 1087-1092.
16. Hill S. J. and Kendall D. A (1987) Studies on the adenosine-receptor mediating the augmentation of histamine induced inositol phospholipid hydrolysis in guinea pig cerebral cortex. Br. J. Pharmacol. 91, 661-669.
17. Hollingsworth E. B., De La Cruz R. A., and Daly J. W. (1986) Accumulation of inositol phosphates and cyclic AMP in brain slices: synergistic interactions of histamine and 2-chloroadenosine. Eur. J. Pharmacol. 122, 45-50.
18. 1 adenosine receptor in CHO-K1 cells to calcium mobilization via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 111, 1252-1256.
19. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251, 888-893.
20. Kendall D. A. and Firth J. L. (1990) Inositol phospholipid hydrolysis in human brain; adenosine inhibition of the response to histamine. Br. J. Pharmacol. 100, 37-40.
21. Kendall D. A. and Hill S. J. (1988) Adenosine inhibition of histamine-stimulated inositol phospholipid hydrolysis in mouse cerebral cortex. J. Neurochem. 50, 497-502.
22. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15, 298-306.
23. Long C. J. and Stone T. W (1987) Adenosine reduces agonist-induced production of inositol phosphates in rat aorta. J. Pharm. Pharmacol. 39, 1010-1014.
24. Marquardt D. L., Walker L. L., and Heinemann S. (1994) Cloning of two A adenosine receptor subtypes from mouse bone marrow-derived mast cells. J. Immunol. 152, 4508-4515.
25. Narang N., Garg L. C., and Crews F. T. (1990) Adenosine and its analogs stimulate phosphoinositide hydrolysis in the kidney. Pharmacology 40, 90-95.
26. Newby A. C. (1984) Adenosine and the concept of "retaliatory metabolites." Trends Biochem. Sci. 9, 42-44.
27. Olah M. E. and Stiles G. L. (1995) Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35, 581-606.
28. Petcoff D. W. and Cooper D. M. F. (1987) Adenosine receptor agonists inhibit inositol phosphate accumulation in rat striatal slices. Eur. J. Pharmacol. 137, 269-271.
29. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268, 16887-16890.
30. Reddington M. and Lee K. S. (1991) Adenosine receptor subtypes: classification and distribution, in Adenosine in the Nervous System (Stone T., ed), pp. 77-102. Academic Press, London.
31. Rudolphi K. A., Schubert P., Parkinson F. F., and Fredholm B. B. (1992) Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13, 439-445.
32. Schweibert E. M., Karlson K. H., Friedman P. A., Dietl P., Spielman W. S., and Stanton B. A. (1992) Adenosine regulates a chloride channel via protein kinase C and a G protein in a rabbit cortical collecting duct cell line. J. Clin. Invest. 89, 834-841.
33. +)-ATPase regulatory system in rabbit aortic wall. Diabetologia 34, 157-163.
34. Stone T., ed (1991) Neuroscience Perspectives: Adenosine in the Nervous System. Academic Press, London.
35. 2b receptor in Xenopus oocytes. Mol. Pharmacol. 43, 277-280.
36. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89, 7432-7436.
37. Zhu X. and Eichberg J. (1990) A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 87, 9818-9822.